{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1361137043529434112.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1016/j.nbd.2011.10.002"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0969996111003342?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0969996111003342?httpAccept=text/plain"}},{"identifier":{"@type":"PMID","@value":"22015601"}}],"dc:title":[{"@value":"Pathophysiology of bladder dysfunction in Parkinson's disease"}],"description":[{"notation":[{"@value":"Bladder dysfunction (urinary urgency/frequency) is a common non-motor disorder in Parkinson's disease (PD). In contrast to motor disorders, bladder dysfunction is sometimes non-responsive to levodopa treatment. The brain pathology causing the bladder dysfunction (appearance of overactivity) involves an altered dopamine basal ganglia-frontal circuit, which normally suppresses the micturition reflex. The pathophysiology of the bladder dysfunction in PD differs from that in multiple system atrophy; therefore, it might aid in differential diagnosis. Anticholinergic agents are used to treat bladder dysfunction in PD, although these drugs should be used with caution particularly in elderly patients who have cognitive decline. These treatments might be beneficial in maximizing the patients' quality of life."}]}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1381137043529434112","@type":"Researcher","foaf:name":[{"@value":"Ryuji Sakakibara"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137043529434115","@type":"Researcher","foaf:name":[{"@value":"Fuyuki Tateno"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137043529434116","@type":"Researcher","foaf:name":[{"@value":"Masahiko Kishi"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137043529434113","@type":"Researcher","foaf:name":[{"@value":"Yohei Tsuyuzaki"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137043529434117","@type":"Researcher","foaf:name":[{"@value":"Tomoyuki Uchiyama"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137043529434114","@type":"Researcher","foaf:name":[{"@value":"Tatsuya Yamamoto"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"09699961"}],"prism:publicationName":[{"@value":"Neurobiology of Disease"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"2012-06","prism:volume":"46","prism:number":"3","prism:startingPage":"565","prism:endingPage":"571"},"reviewed":"false","dcterms:accessRights":"http://purl.org/coar/access_right/c_abf2","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S0969996111003342?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S0969996111003342?httpAccept=text/plain"}],"createdAt":"2011-10-17","modifiedAt":"2025-03-12","foaf:topic":[{"@id":"https://cir.nii.ac.jp/all?q=Dopamine%20D1%20receptors","dc:title":"Dopamine D1 receptors"},{"@id":"https://cir.nii.ac.jp/all?q=Male","dc:title":"Male"},{"@id":"https://cir.nii.ac.jp/all?q=Electromyography","dc:title":"Electromyography"},{"@id":"https://cir.nii.ac.jp/all?q=Parkinson's%20disease","dc:title":"Parkinson's disease"},{"@id":"https://cir.nii.ac.jp/all?q=Dopamine","dc:title":"Dopamine"},{"@id":"https://cir.nii.ac.jp/all?q=Dopamine%20Agents","dc:title":"Dopamine Agents"},{"@id":"https://cir.nii.ac.jp/all?q=Urinary%20Bladder","dc:title":"Urinary Bladder"},{"@id":"https://cir.nii.ac.jp/all?q=Transurethral%20Resection%20of%20Prostate","dc:title":"Transurethral Resection of Prostate"},{"@id":"https://cir.nii.ac.jp/all?q=Urinary%20Bladder%20Diseases","dc:title":"Urinary Bladder Diseases"},{"@id":"https://cir.nii.ac.jp/all?q=Urination","dc:title":"Urination"},{"@id":"https://cir.nii.ac.jp/all?q=Neurosciences.%20Biological%20psychiatry.%20Neuropsychiatry","dc:title":"Neurosciences. Biological psychiatry. Neuropsychiatry"},{"@id":"https://cir.nii.ac.jp/all?q=Parkinson%20Disease","dc:title":"Parkinson Disease"},{"@id":"https://cir.nii.ac.jp/all?q=Urination%20Disorders","dc:title":"Urination Disorders"},{"@id":"https://cir.nii.ac.jp/all?q=Basal%20Ganglia","dc:title":"Basal Ganglia"},{"@id":"https://cir.nii.ac.jp/all?q=Cholinergic%20Antagonists","dc:title":"Cholinergic Antagonists"},{"@id":"https://cir.nii.ac.jp/all?q=Urodynamics","dc:title":"Urodynamics"},{"@id":"https://cir.nii.ac.jp/all?q=Humans","dc:title":"Humans"},{"@id":"https://cir.nii.ac.jp/all?q=Bladder%20dysfunction","dc:title":"Bladder dysfunction"},{"@id":"https://cir.nii.ac.jp/all?q=RC321-571","dc:title":"RC321-571"}],"relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360004230237860352","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Central nervous targets for the treatment of bladder dysfunction"}]},{"@id":"https://cir.nii.ac.jp/crid/1360283694445044608","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Urinary Dysfunction in Progressive Supranuclear Palsy Compared with Other Parkinsonian Disorders"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285708428812288","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Prevalence and treatment of LUTS in patients with Parkinson disease or multiple system atrophy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567179921243008","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Urinary symptoms are correlated with quality of life after deep brain stimulation in Parkinson's disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567185485393024","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Finger taps and constipation are closely related to symptoms of overactive bladder in male patients with<scp>P</scp>arkinson's disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360853567586136960","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"The relationship between lower urinary tract function and 123ioflupane scintigraphy in drug-naïve Parkinson's disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360853567835366912","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Brain hydrogen sulfide suppresses the micturition reflex via brain GABA receptors in rats"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205035223424","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Neurology and the bladder: how to assess and manage neurogenic bladder dysfunction. With particular references to neural control of micturition"},{"@value":"神経内科と膀胱～排尿の神経機序と排尿障害の見方・扱い方～"},{"@language":"ja-Kana","@value":"シンケイ ナイカ ト ボウコウ : ハイニョウ ノ シンケイ キジョ ト ハイニョウ ショウガイ ノ ミカタ ・ アツカイ カタ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282680012849536","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Cognitive adverse effects of anticholinergic medication for overactive bladder in PD/DLB"},{"@language":"ja","@value":"PD/DLBの抗コリン薬と認知機能"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1016/j.nbd.2011.10.002"},{"@type":"OPENAIRE","@value":"doi_dedup___::66179c4a7f2c720e74faf734a321bb92"},{"@type":"CROSSREF","@value":"10.1002/nau.22455_references_DOI_a4wiXhkpUDkz6Aa3PthFqyT47w1"},{"@type":"CROSSREF","@value":"10.1371/journal.pone.0149278_references_DOI_a4wiXhkpUDkz6Aa3PthFqyT47w1"},{"@type":"CROSSREF","@value":"10.1038/nrurol.2016.254_references_DOI_a4wiXhkpUDkz6Aa3PthFqyT47w1"},{"@type":"CROSSREF","@value":"10.1002/brb3.1164_references_DOI_a4wiXhkpUDkz6Aa3PthFqyT47w1"},{"@type":"CROSSREF","@value":"10.1111/iju.12186_references_DOI_a4wiXhkpUDkz6Aa3PthFqyT47w1"},{"@type":"CROSSREF","@value":"10.5692/clinicalneurol.53.1389_references_DOI_a4wiXhkpUDkz6Aa3PthFqyT47w1"},{"@type":"CROSSREF","@value":"10.5692/clinicalneurol.53.181_references_DOI_a4wiXhkpUDkz6Aa3PthFqyT47w1"},{"@type":"CROSSREF","@value":"10.1016/j.autneu.2021.102813_references_DOI_a4wiXhkpUDkz6Aa3PthFqyT47w1"},{"@type":"CROSSREF","@value":"10.1016/j.niox.2020.08.006_references_DOI_a4wiXhkpUDkz6Aa3PthFqyT47w1"}]}